The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC) View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12-20

AUTHORS

Brian I. Rini, Dena Battle, Robert A. Figlin, Daniel J. George, Hans Hammers, Tom Hutson, Eric Jonasch, Richard W. Joseph, David F. McDermott, Robert J. Motzer, Sumanta K. Pal, Allan J. Pantuck, David I. Quinn, Virginia Seery, Martin H. Voss, Christopher G. Wood, Laura S. Wood, Michael B. Atkins

ABSTRACT

The approval of immunotherapeutic agents and immunotherapy-based combination strategies in recent years has revolutionized the treatment of patients with advanced renal cell carcinoma (aRCC). Nivolumab, a programmed death 1 (PD-1) immune checkpoint inhibitor monoclonal antibody, was approved as monotherapy in 2015 for aRCC after treatment with a VEGF-targeting agent. In April 2018, the combination of nivolumab and ipilimumab, a CTLA-4 inhibitor, was approved for intermediate- and poor-risk, previously untreated patients with aRCC. Then, in 2019, combinations therapies consisting of pembrolizumab (anti-PD-1) or avelumab (anti-PD-ligand (L) 1) with axitinib (a VEGF receptor tyrosine kinase inhibitor) were also approved to treat aRCC and are likely to produce dramatic shifts in the therapeutic landscape. To address the rapid advances in immunotherapy options for patients with aRCC, the Society for Immunotherapy of Cancer (SITC) reconvened its Cancer Immunotherapy Guidelines (CIG) Renal Cell Carcinoma Subcommittee and tasked it with generating updated consensus recommendations for the treatment of patients with this disease. More... »

PAGES

354

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s40425-019-0813-8

DOI

http://dx.doi.org/10.1186/s40425-019-0813-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1123532586

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/31856918


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Immunological", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Renal Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Management", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Molecular Targeted Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Practice Guidelines as Topic", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.239578.2", 
          "name": [
            "Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rini", 
        "givenName": "Brian I.", 
        "id": "sg:person.01113325143.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113325143.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "KCCure, Leesburg, VA, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "KCCure, Leesburg, VA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Battle", 
        "givenName": "Dena", 
        "id": "sg:person.012255146260.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012255146260.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cedars-Sinai Medical Center, Los Angeles, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.50956.3f", 
          "name": [
            "Cedars-Sinai Medical Center, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Figlin", 
        "givenName": "Robert A.", 
        "id": "sg:person.0664152550.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664152550.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University School of Medicine, Durham, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Duke University School of Medicine, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "George", 
        "givenName": "Daniel J.", 
        "id": "sg:person.013110637342.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013110637342.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "UT Southwestern, Dallas, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.267313.2", 
          "name": [
            "UT Southwestern, Dallas, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hammers", 
        "givenName": "Hans", 
        "id": "sg:person.01220204543.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01220204543.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Charles A. Sammons Cancer Center, Baylor, Dallas, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Charles A. Sammons Cancer Center, Baylor, Dallas, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hutson", 
        "givenName": "Tom", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jonasch", 
        "givenName": "Eric", 
        "id": "sg:person.01172764022.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172764022.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mayo Clinic, Jacksonville, FL, USA", 
          "id": "http://www.grid.ac/institutes/grid.417467.7", 
          "name": [
            "Mayo Clinic, Jacksonville, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Joseph", 
        "givenName": "Richard W.", 
        "id": "sg:person.0630150147.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630150147.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Beth Israel Deaconess Medical Center, Boston, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.239395.7", 
          "name": [
            "Beth Israel Deaconess Medical Center, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McDermott", 
        "givenName": "David F.", 
        "id": "sg:person.0656541200.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656541200.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Memorial Sloan-Kettering Cancer Center, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Memorial Sloan-Kettering Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Motzer", 
        "givenName": "Robert J.", 
        "id": "sg:person.01234500340.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234500340.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "City of Hope, Duarte, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.410425.6", 
          "name": [
            "City of Hope, Duarte, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pal", 
        "givenName": "Sumanta K.", 
        "id": "sg:person.01162002222.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162002222.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "UCLA School of Medicine, Los Angeles, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.19006.3e", 
          "name": [
            "UCLA School of Medicine, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pantuck", 
        "givenName": "Allan J.", 
        "id": "sg:person.01365327543.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365327543.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Norris Comprehensive Cancer Center, Los Angeles, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.42505.36", 
          "name": [
            "Norris Comprehensive Cancer Center, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Quinn", 
        "givenName": "David I.", 
        "id": "sg:person.01013134010.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013134010.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Beth Israel Deaconess Medical Center, Boston, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.239395.7", 
          "name": [
            "Beth Israel Deaconess Medical Center, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Seery", 
        "givenName": "Virginia", 
        "id": "sg:person.01330202470.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330202470.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Memorial Sloan-Kettering Cancer Center, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Memorial Sloan-Kettering Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Voss", 
        "givenName": "Martin H.", 
        "id": "sg:person.0577111044.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577111044.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wood", 
        "givenName": "Christopher G.", 
        "id": "sg:person.01040121722.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040121722.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.239578.2", 
          "name": [
            "Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wood", 
        "givenName": "Laura S.", 
        "id": "sg:person.010243623117.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010243623117.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Georgetown, Lombardi Comprehensive Cancer Center, Research Building, Room E501 3970 Reservoir Road NW, 20057, Washington, DC, USA", 
          "id": "http://www.grid.ac/institutes/grid.213910.8", 
          "name": [
            "Georgetown, Lombardi Comprehensive Cancer Center, Research Building, Room E501 3970 Reservoir Road NW, 20057, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Atkins", 
        "givenName": "Michael B.", 
        "id": "sg:person.010266621557.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010266621557.13"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nrclinonc.2013.153", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042806557", 
          "https://doi.org/10.1038/nrclinonc.2013.153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12032-018-1147-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103813735", 
          "https://doi.org/10.1007/s12032-018-1147-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s40425-016-0180-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048113477", 
          "https://doi.org/10.1186/s40425-016-0180-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s40425-014-0035-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011546195", 
          "https://doi.org/10.1186/s40425-014-0035-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s40425-019-0522-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1112212877", 
          "https://doi.org/10.1186/s40425-019-0522-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s40425-018-0319-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100689551", 
          "https://doi.org/10.1186/s40425-018-0319-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41591-018-0053-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104306675", 
          "https://doi.org/10.1038/s41591-018-0053-3"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12-20", 
    "datePublishedReg": "2019-12-20", 
    "description": "The approval of immunotherapeutic agents and immunotherapy-based combination strategies in recent years has revolutionized the treatment of patients with advanced renal cell carcinoma (aRCC). Nivolumab, a programmed death 1 (PD-1) immune checkpoint inhibitor monoclonal antibody, was approved as monotherapy in 2015 for aRCC after treatment with a VEGF-targeting agent. In April 2018, the combination of nivolumab and ipilimumab, a CTLA-4 inhibitor, was approved for intermediate- and poor-risk, previously untreated patients with aRCC. Then, in 2019, combinations therapies consisting of pembrolizumab (anti-PD-1) or avelumab (anti-PD-ligand (L) 1) with axitinib (a VEGF receptor tyrosine kinase inhibitor) were also approved to treat aRCC and are likely to produce dramatic shifts in the therapeutic landscape. To address the rapid advances in immunotherapy options for patients with aRCC, the Society for Immunotherapy of Cancer (SITC) reconvened its Cancer Immunotherapy Guidelines (CIG) Renal Cell Carcinoma Subcommittee and tasked it with generating updated consensus recommendations for the treatment of patients with this disease.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s40425-019-0813-8", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1049249", 
        "issn": [
          "2051-1426"
        ], 
        "name": "Journal for ImmunoTherapy of Cancer", 
        "publisher": "BMJ", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "keywords": [
      "advanced renal cell carcinoma", 
      "renal cell carcinoma", 
      "treatment of patients", 
      "cell carcinoma", 
      "immune checkpoint inhibitor monoclonal antibodies", 
      "combination of nivolumab", 
      "Cancer consensus statement", 
      "CTLA-4 inhibitors", 
      "immunotherapy of cancer", 
      "untreated patients", 
      "immunotherapy options", 
      "immunotherapeutic agents", 
      "combination therapy", 
      "consensus statement", 
      "consensus recommendations", 
      "patients", 
      "therapeutic landscape", 
      "immunotherapy", 
      "monoclonal antibodies", 
      "nivolumab", 
      "carcinoma", 
      "treatment", 
      "combination strategies", 
      "ipilimumab", 
      "monotherapy", 
      "axitinib", 
      "therapy", 
      "agents", 
      "cancer", 
      "disease", 
      "antibodies", 
      "VEGF", 
      "inhibitors", 
      "approval", 
      "options", 
      "years", 
      "recommendations", 
      "Subcommittee", 
      "dramatic shift", 
      "rapid advances", 
      "recent years", 
      "advances", 
      "combination", 
      "strategies", 
      "society", 
      "statements", 
      "shift", 
      "landscape"
    ], 
    "name": "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)", 
    "pagination": "354", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1123532586"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s40425-019-0813-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "31856918"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s40425-019-0813-8", 
      "https://app.dimensions.ai/details/publication/pub.1123532586"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-06-01T22:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_808.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s40425-019-0813-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0813-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0813-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0813-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0813-8'


 

This table displays all metadata directly associated to this object as RDF triples.

338 TRIPLES      22 PREDICATES      92 URIs      76 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s40425-019-0813-8 schema:about N482a6ec469d44f4b9af74c28460622af
2 N4e7dcf938e244d5d85ede5082732e618
3 N5c8d073d4597439092d8c20c235ad86c
4 N6b67be36cb9e4b36b5e42fcef422d7fe
5 N74f82486a23e4b6da14dbf5ba14c9f97
6 N96f575d2aaa54b77b63a1bd55380c348
7 Nb4221e3588ad417fb4b403f3328805b1
8 Nbacab7f661a44341b8b466fcf66a3211
9 Nd34a9f6250624859b26dcc17f5ccbe25
10 Nf6bb9163a41747c785748a0dcb190240
11 anzsrc-for:11
12 anzsrc-for:1107
13 anzsrc-for:1112
14 schema:author Nea1e4a70abbb41dcafce8fb8d2483dab
15 schema:citation sg:pub.10.1007/s12032-018-1147-y
16 sg:pub.10.1038/nrclinonc.2013.153
17 sg:pub.10.1038/s41591-018-0053-3
18 sg:pub.10.1186/s40425-014-0035-z
19 sg:pub.10.1186/s40425-016-0180-7
20 sg:pub.10.1186/s40425-018-0319-9
21 sg:pub.10.1186/s40425-019-0522-3
22 schema:datePublished 2019-12-20
23 schema:datePublishedReg 2019-12-20
24 schema:description The approval of immunotherapeutic agents and immunotherapy-based combination strategies in recent years has revolutionized the treatment of patients with advanced renal cell carcinoma (aRCC). Nivolumab, a programmed death 1 (PD-1) immune checkpoint inhibitor monoclonal antibody, was approved as monotherapy in 2015 for aRCC after treatment with a VEGF-targeting agent. In April 2018, the combination of nivolumab and ipilimumab, a CTLA-4 inhibitor, was approved for intermediate- and poor-risk, previously untreated patients with aRCC. Then, in 2019, combinations therapies consisting of pembrolizumab (anti-PD-1) or avelumab (anti-PD-ligand (L) 1) with axitinib (a VEGF receptor tyrosine kinase inhibitor) were also approved to treat aRCC and are likely to produce dramatic shifts in the therapeutic landscape. To address the rapid advances in immunotherapy options for patients with aRCC, the Society for Immunotherapy of Cancer (SITC) reconvened its Cancer Immunotherapy Guidelines (CIG) Renal Cell Carcinoma Subcommittee and tasked it with generating updated consensus recommendations for the treatment of patients with this disease.
25 schema:genre article
26 schema:inLanguage en
27 schema:isAccessibleForFree true
28 schema:isPartOf N809a484f71e8450aabe98be2ba1ac646
29 Nfb6a7ee1256c4845831e473207a46ea9
30 sg:journal.1049249
31 schema:keywords CTLA-4 inhibitors
32 Cancer consensus statement
33 Subcommittee
34 VEGF
35 advanced renal cell carcinoma
36 advances
37 agents
38 antibodies
39 approval
40 axitinib
41 cancer
42 carcinoma
43 cell carcinoma
44 combination
45 combination of nivolumab
46 combination strategies
47 combination therapy
48 consensus recommendations
49 consensus statement
50 disease
51 dramatic shift
52 immune checkpoint inhibitor monoclonal antibodies
53 immunotherapeutic agents
54 immunotherapy
55 immunotherapy of cancer
56 immunotherapy options
57 inhibitors
58 ipilimumab
59 landscape
60 monoclonal antibodies
61 monotherapy
62 nivolumab
63 options
64 patients
65 rapid advances
66 recent years
67 recommendations
68 renal cell carcinoma
69 shift
70 society
71 statements
72 strategies
73 therapeutic landscape
74 therapy
75 treatment
76 treatment of patients
77 untreated patients
78 years
79 schema:name The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
80 schema:pagination 354
81 schema:productId N20b7f6478faa4121ad09b451fcf47083
82 N264f902c76b24cfbab9c86096a36bd6a
83 N84fd0da5f5dd4015b2993e73d1aad54f
84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1123532586
85 https://doi.org/10.1186/s40425-019-0813-8
86 schema:sdDatePublished 2022-06-01T22:21
87 schema:sdLicense https://scigraph.springernature.com/explorer/license/
88 schema:sdPublisher N9b3a8f13b3d546c8883cc507d3d32962
89 schema:url https://doi.org/10.1186/s40425-019-0813-8
90 sgo:license sg:explorer/license/
91 sgo:sdDataset articles
92 rdf:type schema:ScholarlyArticle
93 N0c0f974f97874d289b3528d31744ce65 rdf:first sg:person.013110637342.47
94 rdf:rest N1188cb99acbb4f6ebce4865bc5272f54
95 N1188cb99acbb4f6ebce4865bc5272f54 rdf:first sg:person.01220204543.52
96 rdf:rest N9f2aa8212a5b4fc89f6dfa4d314bb252
97 N20b7f6478faa4121ad09b451fcf47083 schema:name pubmed_id
98 schema:value 31856918
99 rdf:type schema:PropertyValue
100 N264f902c76b24cfbab9c86096a36bd6a schema:name doi
101 schema:value 10.1186/s40425-019-0813-8
102 rdf:type schema:PropertyValue
103 N40adc76754904e5fad458355dd759439 rdf:first sg:person.010243623117.05
104 rdf:rest N78f397d5c82a470a81a3e68d6d01e1e8
105 N482a6ec469d44f4b9af74c28460622af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Neoplasm Staging
107 rdf:type schema:DefinedTerm
108 N4e7dcf938e244d5d85ede5082732e618 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Kidney Neoplasms
110 rdf:type schema:DefinedTerm
111 N5592629ead274fa798a17ebfcdae1617 rdf:first sg:person.01330202470.13
112 rdf:rest Ndeacf0dec4a54938a55041ae6fde7f83
113 N55f7a92ce8f14a3a9073ceb7ef564fa6 rdf:first sg:person.0656541200.82
114 rdf:rest N7772012c65544d80863b75f763f4f3af
115 N58f16dccdc804e89af372a53df0cbbb1 rdf:first sg:person.01040121722.56
116 rdf:rest N40adc76754904e5fad458355dd759439
117 N5c8d073d4597439092d8c20c235ad86c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Biomarkers, Tumor
119 rdf:type schema:DefinedTerm
120 N6b67be36cb9e4b36b5e42fcef422d7fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Humans
122 rdf:type schema:DefinedTerm
123 N70f12374b3a64bf693f7a4967278d819 schema:affiliation grid-institutes:grid.39382.33
124 schema:familyName Hutson
125 schema:givenName Tom
126 rdf:type schema:Person
127 N74f82486a23e4b6da14dbf5ba14c9f97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Immunotherapy
129 rdf:type schema:DefinedTerm
130 N7772012c65544d80863b75f763f4f3af rdf:first sg:person.01234500340.18
131 rdf:rest Ndd6e2b9b5b9a4fc89464ed2854f4905e
132 N78f397d5c82a470a81a3e68d6d01e1e8 rdf:first sg:person.010266621557.13
133 rdf:rest rdf:nil
134 N809a484f71e8450aabe98be2ba1ac646 schema:volumeNumber 7
135 rdf:type schema:PublicationVolume
136 N84fb0bda3180442a95229bba215aed57 rdf:first sg:person.012255146260.77
137 rdf:rest N888be86828ae46d7a7fe01aa7cb93c45
138 N84fd0da5f5dd4015b2993e73d1aad54f schema:name dimensions_id
139 schema:value pub.1123532586
140 rdf:type schema:PropertyValue
141 N888be86828ae46d7a7fe01aa7cb93c45 rdf:first sg:person.0664152550.77
142 rdf:rest N0c0f974f97874d289b3528d31744ce65
143 N9275d24f884a4dd6b0f1c5ad4af0cd3a rdf:first sg:person.0630150147.14
144 rdf:rest N55f7a92ce8f14a3a9073ceb7ef564fa6
145 N96f575d2aaa54b77b63a1bd55380c348 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Carcinoma, Renal Cell
147 rdf:type schema:DefinedTerm
148 N9b3a8f13b3d546c8883cc507d3d32962 schema:name Springer Nature - SN SciGraph project
149 rdf:type schema:Organization
150 N9f2aa8212a5b4fc89f6dfa4d314bb252 rdf:first N70f12374b3a64bf693f7a4967278d819
151 rdf:rest Ne42da52b8ef142c198b673ab19d99d82
152 Nb4221e3588ad417fb4b403f3328805b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Molecular Targeted Therapy
154 rdf:type schema:DefinedTerm
155 Nbacab7f661a44341b8b466fcf66a3211 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Antineoplastic Agents, Immunological
157 rdf:type schema:DefinedTerm
158 Nbf0b333ad12045328c7dd334a6f1b97f rdf:first sg:person.01365327543.53
159 rdf:rest Ncd124faae2374c5fb70dc08533d6bd73
160 Ncd124faae2374c5fb70dc08533d6bd73 rdf:first sg:person.01013134010.15
161 rdf:rest N5592629ead274fa798a17ebfcdae1617
162 Nd34a9f6250624859b26dcc17f5ccbe25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Practice Guidelines as Topic
164 rdf:type schema:DefinedTerm
165 Ndd6e2b9b5b9a4fc89464ed2854f4905e rdf:first sg:person.01162002222.57
166 rdf:rest Nbf0b333ad12045328c7dd334a6f1b97f
167 Ndeacf0dec4a54938a55041ae6fde7f83 rdf:first sg:person.0577111044.36
168 rdf:rest N58f16dccdc804e89af372a53df0cbbb1
169 Ne42da52b8ef142c198b673ab19d99d82 rdf:first sg:person.01172764022.37
170 rdf:rest N9275d24f884a4dd6b0f1c5ad4af0cd3a
171 Nea1e4a70abbb41dcafce8fb8d2483dab rdf:first sg:person.01113325143.17
172 rdf:rest N84fb0bda3180442a95229bba215aed57
173 Nf6bb9163a41747c785748a0dcb190240 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Disease Management
175 rdf:type schema:DefinedTerm
176 Nfb6a7ee1256c4845831e473207a46ea9 schema:issueNumber 1
177 rdf:type schema:PublicationIssue
178 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
179 schema:name Medical and Health Sciences
180 rdf:type schema:DefinedTerm
181 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
182 schema:name Immunology
183 rdf:type schema:DefinedTerm
184 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
185 schema:name Oncology and Carcinogenesis
186 rdf:type schema:DefinedTerm
187 sg:journal.1049249 schema:issn 2051-1426
188 schema:name Journal for ImmunoTherapy of Cancer
189 schema:publisher BMJ
190 rdf:type schema:Periodical
191 sg:person.01013134010.15 schema:affiliation grid-institutes:grid.42505.36
192 schema:familyName Quinn
193 schema:givenName David I.
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013134010.15
195 rdf:type schema:Person
196 sg:person.010243623117.05 schema:affiliation grid-institutes:grid.239578.2
197 schema:familyName Wood
198 schema:givenName Laura S.
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010243623117.05
200 rdf:type schema:Person
201 sg:person.010266621557.13 schema:affiliation grid-institutes:grid.213910.8
202 schema:familyName Atkins
203 schema:givenName Michael B.
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010266621557.13
205 rdf:type schema:Person
206 sg:person.01040121722.56 schema:affiliation grid-institutes:grid.240145.6
207 schema:familyName Wood
208 schema:givenName Christopher G.
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040121722.56
210 rdf:type schema:Person
211 sg:person.01113325143.17 schema:affiliation grid-institutes:grid.239578.2
212 schema:familyName Rini
213 schema:givenName Brian I.
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113325143.17
215 rdf:type schema:Person
216 sg:person.01162002222.57 schema:affiliation grid-institutes:grid.410425.6
217 schema:familyName Pal
218 schema:givenName Sumanta K.
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162002222.57
220 rdf:type schema:Person
221 sg:person.01172764022.37 schema:affiliation grid-institutes:grid.240145.6
222 schema:familyName Jonasch
223 schema:givenName Eric
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172764022.37
225 rdf:type schema:Person
226 sg:person.01220204543.52 schema:affiliation grid-institutes:grid.267313.2
227 schema:familyName Hammers
228 schema:givenName Hans
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01220204543.52
230 rdf:type schema:Person
231 sg:person.012255146260.77 schema:affiliation grid-institutes:None
232 schema:familyName Battle
233 schema:givenName Dena
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012255146260.77
235 rdf:type schema:Person
236 sg:person.01234500340.18 schema:affiliation grid-institutes:grid.51462.34
237 schema:familyName Motzer
238 schema:givenName Robert J.
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234500340.18
240 rdf:type schema:Person
241 sg:person.013110637342.47 schema:affiliation grid-institutes:grid.26009.3d
242 schema:familyName George
243 schema:givenName Daniel J.
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013110637342.47
245 rdf:type schema:Person
246 sg:person.01330202470.13 schema:affiliation grid-institutes:grid.239395.7
247 schema:familyName Seery
248 schema:givenName Virginia
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330202470.13
250 rdf:type schema:Person
251 sg:person.01365327543.53 schema:affiliation grid-institutes:grid.19006.3e
252 schema:familyName Pantuck
253 schema:givenName Allan J.
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365327543.53
255 rdf:type schema:Person
256 sg:person.0577111044.36 schema:affiliation grid-institutes:grid.51462.34
257 schema:familyName Voss
258 schema:givenName Martin H.
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577111044.36
260 rdf:type schema:Person
261 sg:person.0630150147.14 schema:affiliation grid-institutes:grid.417467.7
262 schema:familyName Joseph
263 schema:givenName Richard W.
264 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630150147.14
265 rdf:type schema:Person
266 sg:person.0656541200.82 schema:affiliation grid-institutes:grid.239395.7
267 schema:familyName McDermott
268 schema:givenName David F.
269 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656541200.82
270 rdf:type schema:Person
271 sg:person.0664152550.77 schema:affiliation grid-institutes:grid.50956.3f
272 schema:familyName Figlin
273 schema:givenName Robert A.
274 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664152550.77
275 rdf:type schema:Person
276 sg:pub.10.1007/s12032-018-1147-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1103813735
277 https://doi.org/10.1007/s12032-018-1147-y
278 rdf:type schema:CreativeWork
279 sg:pub.10.1038/nrclinonc.2013.153 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042806557
280 https://doi.org/10.1038/nrclinonc.2013.153
281 rdf:type schema:CreativeWork
282 sg:pub.10.1038/s41591-018-0053-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104306675
283 https://doi.org/10.1038/s41591-018-0053-3
284 rdf:type schema:CreativeWork
285 sg:pub.10.1186/s40425-014-0035-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1011546195
286 https://doi.org/10.1186/s40425-014-0035-z
287 rdf:type schema:CreativeWork
288 sg:pub.10.1186/s40425-016-0180-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048113477
289 https://doi.org/10.1186/s40425-016-0180-7
290 rdf:type schema:CreativeWork
291 sg:pub.10.1186/s40425-018-0319-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100689551
292 https://doi.org/10.1186/s40425-018-0319-9
293 rdf:type schema:CreativeWork
294 sg:pub.10.1186/s40425-019-0522-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112212877
295 https://doi.org/10.1186/s40425-019-0522-3
296 rdf:type schema:CreativeWork
297 grid-institutes:None schema:alternateName KCCure, Leesburg, VA, USA
298 schema:name KCCure, Leesburg, VA, USA
299 rdf:type schema:Organization
300 grid-institutes:grid.19006.3e schema:alternateName UCLA School of Medicine, Los Angeles, CA, USA
301 schema:name UCLA School of Medicine, Los Angeles, CA, USA
302 rdf:type schema:Organization
303 grid-institutes:grid.213910.8 schema:alternateName Georgetown, Lombardi Comprehensive Cancer Center, Research Building, Room E501 3970 Reservoir Road NW, 20057, Washington, DC, USA
304 schema:name Georgetown, Lombardi Comprehensive Cancer Center, Research Building, Room E501 3970 Reservoir Road NW, 20057, Washington, DC, USA
305 rdf:type schema:Organization
306 grid-institutes:grid.239395.7 schema:alternateName Beth Israel Deaconess Medical Center, Boston, MA, USA
307 schema:name Beth Israel Deaconess Medical Center, Boston, MA, USA
308 rdf:type schema:Organization
309 grid-institutes:grid.239578.2 schema:alternateName Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA
310 schema:name Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA
311 rdf:type schema:Organization
312 grid-institutes:grid.240145.6 schema:alternateName MD Anderson Cancer Center, Houston, TX, USA
313 schema:name MD Anderson Cancer Center, Houston, TX, USA
314 rdf:type schema:Organization
315 grid-institutes:grid.26009.3d schema:alternateName Duke University School of Medicine, Durham, NC, USA
316 schema:name Duke University School of Medicine, Durham, NC, USA
317 rdf:type schema:Organization
318 grid-institutes:grid.267313.2 schema:alternateName UT Southwestern, Dallas, TX, USA
319 schema:name UT Southwestern, Dallas, TX, USA
320 rdf:type schema:Organization
321 grid-institutes:grid.39382.33 schema:alternateName Charles A. Sammons Cancer Center, Baylor, Dallas, TX, USA
322 schema:name Charles A. Sammons Cancer Center, Baylor, Dallas, TX, USA
323 rdf:type schema:Organization
324 grid-institutes:grid.410425.6 schema:alternateName City of Hope, Duarte, CA, USA
325 schema:name City of Hope, Duarte, CA, USA
326 rdf:type schema:Organization
327 grid-institutes:grid.417467.7 schema:alternateName Mayo Clinic, Jacksonville, FL, USA
328 schema:name Mayo Clinic, Jacksonville, FL, USA
329 rdf:type schema:Organization
330 grid-institutes:grid.42505.36 schema:alternateName Norris Comprehensive Cancer Center, Los Angeles, CA, USA
331 schema:name Norris Comprehensive Cancer Center, Los Angeles, CA, USA
332 rdf:type schema:Organization
333 grid-institutes:grid.50956.3f schema:alternateName Cedars-Sinai Medical Center, Los Angeles, CA, USA
334 schema:name Cedars-Sinai Medical Center, Los Angeles, CA, USA
335 rdf:type schema:Organization
336 grid-institutes:grid.51462.34 schema:alternateName Memorial Sloan-Kettering Cancer Center, New York, NY, USA
337 schema:name Memorial Sloan-Kettering Cancer Center, New York, NY, USA
338 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...